How to Conduct Post-Market Surveillance for Overseas Registration of Active Medical Devices?

Post-market surveillance (PMS) for active medical devices after overseas registration is not a task that ends once the registration certificate is obtained; it is a continuous compliance process throughout the certificate's validity. Manufacturers must first determine whether the product falls under the medical device regulatory scope in the target country and identify the registration pathway corresponding to its risk classification. Next, evaluate whether existing NMPA, CE, or FDA documentation can be reused—particularly IEC 60601 series safety standards, EMC, risk management, software lifecycle, and clinical evaluation evidence. The core of post-market surveillance includes registration certificate maintenance, technical file updates, change notifications, adverse event reporting, labeling and instructions for use control, local agent collaboration, and maintaining an effective quality management system.

Applicable Scenarios and Core Issues

Active medical devices are those that rely on electrical energy or other power sources to perform their intended functions, such as patient monitors, electrocardiographs, high-frequency electrosurgical units, medical laser equipment, infusion pumps, and defibrillators. When planning to register and market these devices overseas, companies must not only obtain the certificate but also continuously meet the post-market requirements of the regulatory authority in the registration country.

In this context, overseas registration post-market surveillance refers to the period after the product obtains its registration certificate or marketing authorization. The manufacturer must maintain the certificate, update technical files, report adverse events, handle changes, cooperate with recalls, and keep the quality management system effective. Many companies treat overseas registration as a one-off project and stop investing after obtaining the certificate, only to discover expired documentation when renewal or complaints arise.

In reality, overseas regulators generally regard post-market surveillance as the foundation for the continued validity of a registration certificate. Companies need to consider long-term maintenance during the initial registration planning phase, rather than arranging it only after registration succeeds.

Registration Determination Logic

First, determine whether the product falls within the medical device regulatory scope in the target country. Some countries exclude cleaning and disinfection equipment, rehabilitation training devices, and non-medical electronic devices from medical device regulations, while others include them. If the product is not a medical device, only general electrical safety and electromagnetic compatibility requirements apply.

Next, assess the risk classification, registration pathway, and applicant entity. Risk classification is usually based on the country's classification rules. The same product may be Class II in China but Class IIb in the target country, leading to different registration pathways and requirements. Companies must verify the classification using the target country's official classification guidance.

Then, evaluate whether existing documentation can be reused. If the company holds an NMPA registration certificate, CE marking, or FDA 510(k) clearance, the associated risk management reports, declarations of conformity, test reports, and clinical evaluations or clinical evidence can serve as a basis. ISO 13485 certificates and MDSAP certificates demonstrate quality management system capability and are generally directly acceptable as quality system evidence.

Further confirm technical files, performance verification, risk management, clinical evaluation or evidence, labeling and instructions for use, local agents, authorized representatives, and post-market maintenance requirements. For active devices, special attention must be given to electrical safety, electromagnetic compatibility, wireless coexistence, software lifecycle, cybersecurity, and programmable electronic system requirements.

For scenarios involving GHWP member countries, multi-country registrations, Southeast Asia, the Middle East, and Latin America, emphasize the reuse of core technical files and localization conversion. For example, safety test reports in Chinese registration data that align with IEC 60601 series standards can be converted for use in many countries, but labeling and instructions for use must be in the local language and list the local agent information.

Documentation and Evidence

For post-market surveillance, the following documentation should be prepared:

• Registration certificate and validity period information.
• Managed versions of technical files.
• Quality management system records.
• Risk management documents, including PMS plan and PMS report.
• Adverse event reporting records.
• Change control records.
• Local agent agreements.
• Post-market surveillance plan and periodic safety update reports.

If the target country requires additional clinical follow-up or real-world data, corresponding protocols must also be prepared.

Common special evidence for active devices includes software validation records, RF wireless testing, cybersecurity testing, usability engineering reports, and EMC test reports. These materials are not submitted once and forgotten; subsequent version updates, software fixes, and hardware improvements require synchronized updates to the technical files.

Common Errors

The following errors repeatedly occur in post-market surveillance. Companies should proactively check for them:

• Stopping maintenance of technical files after obtaining the certificate, and failing to update registration data after product revisions.
• Directly translating Chinese labels into English or the target language without recreating them according to local regulations.
• Being unclear about the duties and authority of the local agent, with certificate control in the agent's hands.
• Failing to establish an adverse event reporting process, or not reporting incidents to the registration country within the required timeframe.
• Concealing or failing to notify critical changes during the certificate's validity period.
• Ignoring target country updates for labels, instructions for use, and warning statements.
• Using different versions of technical files for multiple country registrations, leading to uncertainty about the latest version during corrective actions.
• Allowing the quality management system certificate to expire without renewal, affecting the validity of the registration certificate.

Enterprise Preparation Checklist

Companies can progressively establish a post-market surveillance mechanism using the following checklist:

• Create an overseas product archive that centrally manages registration certificates, technical files, test reports, agent agreements, and change records.
• Set up a certificate expiry reminder mechanism, preparing renewal materials at least 12 months in advance.
• Define the response process when product classification rules change, such as re-evaluating after the target country updates its classification guidance.
• Sign clear service agreements with local agents, defining their responsibilities in notifications, changes, renewals, and recalls.
• Establish an adverse event monitoring process with incident report templates in English or the target language.
• Regularly audit technical file versions to ensure consistency with the current production product.
• Use platform-based technical files for multi-country registrations, maintaining localized annexes per country requirements.
• Retain sales records, complaint records, repair records, and field issue analyses as inputs for PMS.

AIMEILI's Perspective

The most common misconception among companies is that obtaining a registration certificate means they can rest indefinitely. Regulatory authorities are increasingly scrutinizing post-market surveillance, and registration certificates often come with conditions. If a company does not invest continuously, the first renewal may fail.

In the early project phase, a gap analysis should be conducted to determine the target country's post-market surveillance regulatory requirements and then assess whether internal processes can meet them, rather than trying to remedy expired technical files later. Most technical files can be reused. The safety, EMC, risk management, usability reports, and clinical evidence accumulated from Chinese registration, CE registration, and FDA registration—provided the versions are consistent and the product has not undergone critical changes—can be the basis for overseas registration. What cannot be reused are labels, instructions for use, local agent documents, the registration country's language, and some country-specific report formats.

The local agent is not merely a recipient of correspondence. They also have statutory duties including communicating with the regulatory authority, handling recalls, receiving adverse event reports, and maintaining documentation. Whether the agent is stable, the ownership of certificate control, and the smoothness of the change process directly affect the certificate's continued validity. If a company prepares a fully separate set of documents for each country in multi-country registration, version confusion, poor reuse of test reports, and correction risks are likely. Companies should establish a platform-based technical file, using the basic safety and EMC reports, risk management reports, and clinical evaluation modules as master files, and then generate localized annexes for each target country.

This approach reduces duplication of effort and allows quick identification of relevant evidence when regulators raise supplementary questions. Post-market surveillance is not a final step; it should be embedded into the company's quality management system and project management process from the initial registration planning stage.

Common Follow-up Questions

How long is the validity period for overseas registration certificates, and how far in advance should renewal preparations begin?

Different countries have different rules. Some countries have a registration certificate validity of 5 years, others 3 years, and some regions initially have indefinite validity but require annual updates. A common practice is to begin preparing renewal materials 12 months in advance because resubmission of technical files, production quality system evidence, local agent information, and post-market surveillance reports is required, and the review cycle may last several months.

If an adverse event occurs overseas, what should the company do first?

First, determine whether the event meets the reporting criteria under the registration country's regulations. Submit a report to the local regulatory authority within the required timeframe, and simultaneously notify the local agent. If the event could cause serious patient injury or death, reporting is typically required within a specified number of hours. The company must also preserve original evidence and cooperate with regulatory investigations.

When registering in multiple countries, can the company prepare entirely independent documentation sets for each country?

It is not recommended to prepare fully independent sets. Multi-country registration should adopt a platform-file and localized-annex model, using the reusable electrical safety, EMC, risk management, and clinical evaluation materials as the master file, then generating localized content according to the target country's language, labeling requirements, and special regulatory requirements. This improves consistency and reduces version confusion and correction risks.